Description

Salofalk (mesalazine) Coated Enteric Tablets 250 mg. №100

Ingredients:

Each tablet contains 250 mg of mesalazine.

Dosage:

The usual adult dose is 1 to 4 tablets daily, as directed by a healthcare provider.

Indications:

Salofalk tablets are indicated for the treatment of mild to moderate ulcerative colitis and Crohn’s disease.

Contraindications:

Do not use Salofalk if you are allergic to mesalazine or any other ingredients in the tablets.

Directions:

Swallow the tablets whole with water, do not crush or chew them. Follow the dosage instructions provided by your doctor.

Scientific Evidence:

Studies have shown that mesalazine, the active ingredient in Salofalk, is effective in inducing and maintaining remission in patients with ulcerative colitis and Crohn’s disease. Research published in the Journal of Crohn’s and Colitis demonstrated the efficacy of mesalazine in reducing inflammation in the colon and improving symptoms in patients with inflammatory bowel diseases.

Additional Information:

It is important to take Salofalk exactly as prescribed by your healthcare provider to achieve the best results. In case of any side effects or concerns, consult your doctor immediately. Store the tablets in a cool, dry place away from direct sunlight.

Salofalk tablets work by releasing mesalazine in the colon, where it exerts its anti-inflammatory effects locally. Mesalazine inhibits the production of inflammatory mediators and promotes tissue healing in the gastrointestinal tract. This mechanism helps in reducing symptoms and maintaining remission in patients with ulcerative colitis and Crohn’s disease.